Medicine
Technetium tc-99m sestamibi 1 mg/mL powder for injection
Technetium tc-99m sestamibi 1 mg/mL powder for injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 15 °C to 25 °C (59 °F to 77 °F) before and after reconstitution.
Key facts
- Active ingredient (INN)
- Technetium tc-99m sestamibi
- Brand
- Sold under the generic name
- Strength
- 1 mg/mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 5 vials, 10 vials, 30 vials
- Manufacturer
- Jubilant DraxImageIndia
- Origin register
- US FDA, United States
- Storage
- Store at 15 °C to 25 °C (59 °F to 77 °F) before and after reconstitution.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V09GA01 Technetium tc-99m sestamibi
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 July 2009
- Identifiers
- DailyMed set ID 07c893fc-cfba-1d98-0232-6448463afb87NDC 45548-141Application ANDA078806
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 vial in 1 kit / 10 mL in 1 vial | 45548-141-05 | Jubilant DraximageIndia | 1 July 2009 |
| 10 vial in 1 kit / 10 mL in 1 vial | 45548-141-10 | Jubilant DraximageIndia | 1 July 2009 |
| 30 vial in 1 kit / 10 mL in 1 vial | 45548-141-30 | Jubilant DraximageIndia | 1 July 2009 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Technetium tc-99m sestamibi
Clinical summary
Technetium tc-99m sestamibi is a radioactive diagnostic agent indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), among other approved uses. MedsAcross supplies Technetium tc-99m sestamibi for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Technetium tc-99m sestamibiFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TECHNETIUM TC 99M SESTAMIBI prescribing information (Jubilant Draximage) · U.S. National Library of Medicine, DailyMed
Need Technetium tc-99m sestamibi 1 mg/mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.